SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 07, 16:00
3185.40
-3.65 (-0.11%)
VOLUME 12,054
LIVE
NSE
Dec 07, 15:57
3183.80
-12.1 (-0.38%)
VOLUME 153,459
Announcements on Dr Reddys Labs

5th-Dec-2016 11:48Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding allotment of 15850 Equity Shares under ESOP

5th-Dec-2016 11:24Source: BSE

Dr Reddys Labs- Allotment of Equity Shares on exercise of ESOP

Dr Reddys Laboratories Ltd has informed BSE that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 15,850 equity shares of Rs. 5/- each of the C...

5th-Dec-2016 11:14Source: BSE

Dr Reddys Labs- Dr. Reddy's Laboratories announces the launch of Nystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated December 05, 2016, titled "Dr. Reddy''s Laboratories announces the launch of Nystatin and Triamcinolone Acetonide Cream, USP...

5th-Dec-2016 11:13Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated December 05, 2016, titled "Dr. Reddy''s Laboratories announces the launch ofNystatin and Triamcinolone Aceto...

16th-Nov-2016 13:30Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company vide a circular resolution passed on Novemb...

16th-Nov-2016 12:10Source: BSE

Dr Reddys Labs- Grant of Stock Options

Dr Reddys Laboratories Ltd has informed BSE that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company vide a circular resolution passed on November 15, 2016, ha...

11th-Nov-2016 14:57Source: BSE

Dr Reddys Labs- Dr. Reddy's Laboratories announces the launch of Raloxifene HCI Tablets, USP in the U.S. Market

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated November 11, 2016 titled "Dr. Reddy''s Laboratories announces the launch of Raloxifene HCI Tablets, USP in the U.S. Market".

11th-Nov-2016 14:55Source: BSE

Dr Reddys Labs- Updates

Dr Reddys Laboratories Ltd has informed BSE that the Company has filed its unaudited consolidated financial statements prepared under IFRS in Form 6-K for the quarter ended September 30, 2016, with th...

7th-Nov-2016 14:08Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2016.

26th-Oct-2016 17:54Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 26, 2016 titled "Dr. Reddy's Laboratories announces new strategic deal with Gland Pharma in the U.S. ...

1 2 3 4 5 Next >>
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.